Table 1.
Comparison of the clinical and epidemiological profile of patients hospitalized with HRV- vs. other CRV-monoinfections, 2012–2013.
| HRV (group 1) | CRV (group 2) | Unadjusted analyses | Adjusted analyses | |
|---|---|---|---|---|
| n = 60 (%) | n = 196 (%) | p-value | p-value | |
| Gender | ||||
| Male | 35 (58) | 92 (47) | 0.14 | – |
| Age | ||||
| <2 years | 34 (57) | 138 (70) | ||
| 2–5 years | 9 (15) | 15 (8) | ||
| 5–14 years | 4 (7) | 10 (6) | ||
| 14–50 years | 7 (12) | 11 (7) | ||
| >50 years | 6 (9) | 17 (9) | ||
| Median, years | 1.3 | 0.6 | 0.16 | NS |
| (IQR) | (0.2–8) | (0.2–2.8) | ||
| Length of hospitalization | ||||
| <5 days | 30 (50) | 49 (25) | ||
| 5–15 days | 24 (40) | 109 (55) | ||
| 15–30 days | 4 (7) | 19 (10) | ||
| >30 days | 2 (3) | 19 (10) | ||
| Median, days | 4.5 | 7 | 0.0032 | NS |
| (IQR) | (2–9) | (4.2–12) | ||
| Symptoms | ||||
| Fever | 37 (62) | 168 (85) | 0.001 | NS |
| Cough | 55 (92) | 189 (96) | 0.15 | |
| Dyspnea | 56 (93) | 183 (93) | 0.95 | |
| Radiological findings | ||||
| Missed | 34 (57) | 76 (39) | ||
| Normal | 6 (10) | 18(9) | 0.98 | |
| Interstitial infiltrate | 8 (13) | 38 (19) | ||
| Pulmonary consolidation | 9 (15) | 35 (15) | ||
| Mixed patterns | 2 (3) | 13 (9) | ||
| Other findingsa | 1 (2) | 16 (9) | ||
| Comorbidities | ||||
| Yes | 24 (40) | 52 (27) | 0.043 | 0.033 |
| Immunosuppression | 10 (17) | 23 (12) | 0.37 | |
| Chronic lung disease | 10 (17) | 24 (12) | 0.37 | |
| Chronic heart disease | 5 (8) | 9 (5) | 0.067 | |
| Mechanical ventilation | 12 (20) | 36 (18) | 0.72 | |
| ICU | 18 (30) | 65 (33) | 0.60 | |
| Death | 2 (3) | 6 (3) | 0.53 | |
| SARI diagnosis | 36 (60) | 165 (84) | 0.006 | NS |
HRV, human rhinovirus; CRV, community-acquired respiratory virus; IQR, interquartile range, ICU, intensive care unit; SARI, severe acute respiratory infections; NS, not significant, OR, odds ratio.
Bold values are in statistically significant.
a
Pleural effusion, atelectasis.